<DOC>
	<DOCNO>NCT02211976</DOCNO>
	<brief_summary>Pilot study evaluate efficacy tolerability combine treatment bisacodyl simeticone compare efficacy tolerability single product patient suffer constipation bloatedness</brief_summary>
	<brief_title>Efficacy Tolerability Bisacodyl Sugar Coated Tablets , Simeticone Chewing Tablets Their Combination Constipation Bloatedness</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Bisacodyl</mesh_term>
	<mesh_term>Simethicone</mesh_term>
	<criteria>Diagnosis constipation , define acute habitual constipation ; concomitantly patient must complaint bloated feeling Patient 18 year age old Females child bear potential must negative prestudy urine pregnancy test must use oral barrier contraceptive method throughout study . If oral contraceptive use , patient must use least 3 month prior enrolment study Patient must willing maintain diary throughout study Patient must otherwise good health Patient must sign informed consent form prepare accordance Declaration Helsinki Patient druginduced constipation result drug opioids , dopaminergics , antacid , anticholinergic diuretic Patient history organic disease colon tumor , stricture , acute chronic inflammatory disease , ileus , acute surgical abdominal condition acute appendicitis , organic disease rectum anus fissure , fistula , perianal abscess , eczema perianal skin Patient exhibit evidence active gastrointestinal disease Patient diagnose intestinal obstruction , undiagnosed abdominal symptom , severe dehydration Patient history major gastrointestinal surgery Patient history hypersensitivity substance triarylmethane class Patient history hypersensitivity substance class parahydroxybenzoic ester ( para group allergy ) Patient history drug alcohol abuse Patient receive bisacodyl treatment another indication previous study within last 7 day enrolment . Patient ingest drug past week enrolment opinion investigator would effect gastrointestinal motility ( e.g . anticholinergic medication , opioids , smooth muscle relaxant antacid ) Patient require use drug , study drug , dietary supplement relieve symptom constipation time baseline treatment phase study Patient currently take form tetracycline antibiotic Patient nursing mother Patient receive investigational drug within previous 4 week prior enrolment Patient condition would interfere completion study , would decrease likelihood obtain valid result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>